| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in GUTS over the last quarter tilts toward buying: insiders added a net 64,516 shares worth roughly $40K.
Classified under Biotechnology (Health Care sector), GUTS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 540.6K | $394.7K | - | |
| Dir | 149.1K | $92.2K | - | |
| Dir | 40.9K | $34.8K | - | |
| Dir | 35.0K | $25.5K | - | |
| CFO | 20.0K | $13.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Bradley William | Director | Buy | 64,516 | $0.62 | $39,903.15 | +76.2% | - | - | |
| Jun 12, 2026 | Royan Ajay | Director | Buy | 23,000 | $0.85 | $19,596.00 | +128.5% | -24.4% | - | |
| Jun 10, 2026 | Sheffield Ian | Director | Buy | 35,000 | $0.73 | $25,529.00 | New | -6.4% | - | |
| Jun 10, 2026 | Rajagopalan Harith74 | Chief Executive Officer | Buy | 25,000 | $0.73 | $18,252.50 | +4.8% | -6.4% | - | |
| Jun 10, 2026 | Bradley William | Director | Buy | 68,493 | $0.73 | $50,328.66 | +424.7% | -6.4% | - | |
| Jun 8, 2026 | Smith Weber Lara | Chief Financial Officer | Buy | 20,000 | $0.69 | $13,708.00 | New | +2.2% | - | |
| Dec 4, 2025 | Rajagopalan Harith74 | Chief Executive Officer | Buy | 10,416 | $1.92 | $19,998.72 | +2.1% | -74.8% | - | |
| Mar 14, 2025 | Barnes Kelly Ann | Director | Buy | 31,000 | $1.30 | $40,210.10 | New | +69.5% | -63.6% | |
| Mar 14, 2025 | Royan Ajay | Director, 10% Owner | Buy | 17,901 | $1.28 | $22,979.51 | New | +69.5% | -63.6% | |
| Mar 13, 2025 | Schulman Amy W | Director | Buy | 8,550 | $1.17 | $9,964.17 | New | +88.4% | -61.3% |